Biomarker Research
Biomarker Research is a peer-reviewed open access journal published by BioMed Central, launched in 2013 and covering all aspects of biomarker investigation, with a 2025 Journal Impact Factor of 14.6《生物标志物研究》是由(BioMed Central)出版的同行评审开放获取期刊,2013 年创刊,涵盖生物标志物研究的各个方面,2025 年影响因子为 14.6。
Scope
- It encompasses all aspects of biomarker investigation across the biomedical disciplines该刊涵盖各生物医学学科中生物标志物研究的各个方面。
- It publishes original discoveries, novel concepts, commentaries and reviews该刊发表原创发现、新概念、评论与综述。
- It covers the identification and validation of biomarkers in drug discovery and development其涵盖药物发现与开发中生物标志物的识别与验证。
- It addresses biomarkers in disease diagnosis, treatment, prognosis and prevention该刊关注疾病诊断、治疗、预后与预防中的生物标志物。
- It emphasises personalised medicine and individual health该刊强调个体化医疗与个体健康。
- Its topics span molecular biology, oncology, immunology and clinical laboratory science其主题横跨分子生物学、肿瘤学、免疫学与临床检验科学。
History
- It was launched in 2013 by BioMed Central该刊于 2013 年由(BioMed Central)创刊。
- Its first article appeared in volume 1, issue 1 in 2013其首篇论文发表于 2013 年第 1 卷第 1 期。[1]
- It has been fully open access since its launch该刊自创刊起即为完全开放获取。
- It uses continuous publication with a single volume per year该刊采用连续出版模式,每年一卷。
- Its Journal Impact Factor moved from 6.148 in 2021 and 11.5 in 2024 to 14.6 in 2025其影响因子由 2021 年的 6.148、2024 年的 11.5 变化到 2025 年的 14.6。
- In the 2025 Journal Citation Reports it ranks seventh among 191 journals in Medicine, Research and Experimental在 2025 年期刊引证报告中,该刊在医学研究与实验类别的 191 种期刊中位列第七。
Editors
- Its Editors-in-Chief are Chung-Tsen Hsueh and Delong Liu其主编为 Chung-Tsen Hsueh 与 Delong Liu。
- Chung-Tsen Hsueh is based at Loma Linda UniversityChung-Tsen Hsueh 任职于(Loma Linda University)。
- Delong Liu is based at New York Medical CollegeDelong Liu 任职于(New York Medical College)。
- Yangfu Jiang of Sichuan University serves as a Section Editor(Sichuan University)的 Yangfu Jiang 担任学科编辑。
- Hua Zhang and Yi Zhang also serve as Section EditorsHua Zhang 与 Yi Zhang 亦担任学科编辑。
- It operates a single-blind peer review system该刊实行单盲同行评审制度。
References
- ^Novel biomarkers for diagnosis, prognosis, targeted therapy and clinical trials. Biomarker Research, 2013, 1(1). doi:10.1186/2050-7771-1-1